Products

Compare Products

Side-by-side comparison of veterinary products

1 Products
Vanguard crLyme
Vanguard crLyme
Biological

Injection

Zoetis

Borrelia burgdorferi chimeric recombinant OspA and OspC proteins

Search to add a product

Search to add a product

Attribute Vanguard crLyme
Image Vanguard crLyme
Trade Name Vanguard crLyme

فانجارد سي آر لايم
Product Type Biological
Dosage Form Injection
Manufacturer Zoetis
Active Ingredients
Diseases —
Package Size 25 x 1-dose and 50 x 1-dose single-use glass vials with sterile diluent
Storage Conditions Store in refrigerator at 2°C to 8°C (35°F to 45°F). Prolonged exposure to higher temperatures may affect potency. Do not freeze.
Dosages

Dog

  • 1 mL (Subcutaneous (SC)) — Primary 2 doses 3 weeks apart; annual revaccination
Withdrawal Periods —
Indications
  • Vaccination of healthy dogs 8 weeks of age or older as an aid in preventing clinical signs of Lyme disease and Borrelia burgdorferi infection.
  • Dual-defense blocking of Borrelia burgdorferi transmission in the tick vector and prevention of systemic canine dissemination.
Contraindications
  • Do not vaccinate debilitated, immunocompromised, or febrile dogs.
Precautions
  • Contains gentamicin as a preservative.
  • In case of anaphylaxis, administer epinephrine immediately.
Side Effects
  • Transient localized discomfort or mild swelling at injection site; lethargy or mild pyrexia resolving within 24 hours.

This website uses cookies to ensure you get the best experience.